4.4 Article

Bladder cancer biomarker screening based on non-targeted urine metabolomics

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics

Joana Pinto et al.

Summary: Timely diagnosis is crucial for improving the long-term survival of bladder cancer patients. A study was conducted to analyze the urinary volatile profile of BC patients using urine samples, revealing distinct volatile signatures and potential biomarkers for non-invasive detection and staging. The results showed differences in urinary volatile profiles among patients diagnosed at different tumor stages, suggesting a promising approach for BC diagnosis and staging.

METABOLITES (2021)

Article Biochemistry & Molecular Biology

MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights

Zhiqiang Pang et al.

Summary: MetaboAnalyst version 5.0 has been introduced to facilitate comprehensive metabolomics data analysis and interpretation, with the aim of narrowing the gap from raw data to functional insights. Three new modules have been developed to assist in this goal, along with various other new functions and improvements in interface, graphics, and codebase. Users can now easily switch between compatible modules for a streamlined data analysis experience.

NUCLEIC ACIDS RESEARCH (2021)

Review Pathology

Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers

Antonio Lopez-Beltran et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2020)

Review Urology & Nephrology

Cancer metabolomic markers in urine: evidence, techniques and recommendations

Sarah S. Dinges et al.

NATURE REVIEWS UROLOGY (2019)

Article Endocrinology & Metabolism

Recognition of early and late stages of bladder cancer using metabolites and machine learning

Valentina L. Kouznetsova et al.

METABOLOMICS (2019)

Review Medicine, Research & Experimental

Metabolic pathways of L-arginine and therapeutic consequences in tumors

Jaroslaw Szefel et al.

ADVANCES IN MEDICAL SCIENCES (2019)

Review Pharmacology & Pharmacy

NAD+ salvage pathway in cancer metabolism and therapy

Barry E. Kennedy et al.

PHARMACOLOGICAL RESEARCH (2016)

Review Health Care Sciences & Services

False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies

Mark E. Glickman et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)

Article Multidisciplinary Sciences

Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine

Bryan M. Wittmann et al.

PLOS ONE (2014)

Article Biochemical Research Methods

Identification of Potential Biomarkers for Ovarian Cancer by Urinary Metabolomic Profiling

Tao Zhang et al.

JOURNAL OF PROTEOME RESEARCH (2013)

Article Biochemical Research Methods

Bladder Cancer Determination Via Two Urinary Metabolites: A Biomarker Pattern Approach

Zhenzhen Huang et al.

MOLECULAR & CELLULAR PROTEOMICS (2011)

Article Biochemical Research Methods

Noninvasive Urinary Metabonomic Diagnosis of Human Bladder Cancer

Kishore Kumar Pasikanti et al.

JOURNAL OF PROTEOME RESEARCH (2010)

Article Oncology

Promotion of bladder cancer development and progression by androgen receptor signals

Hiroshi Miyamoto et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)